Literature DB >> 10421534

Variability of the location of internal mammary vessels and glandular breast tissue in breast cancer patients undergoing routine CT-based treatment planning.

G Bentel1, L B Marks, P Hardenbergh, L Prosnitz.   

Abstract

PURPOSE: To determine the variability of position of internal mammary vessels (IMV) and glandular breast tissue (GBT) in patients undergoing breast-conserving radiation therapy. To assess the frequency and magnitude of tangential field border shifts based on preradiation therapy (RT) computed tomography (CT) imaging in breast cancer patients. METHODS AND MATERIALS: Five hundred and ninety breast cancer patients irradiated between 9/94 and 3/98 underwent routine CT-based treatment planning. Two analyses were performed. First, the position of IMV and GBT, outlined on the central axis CT image, was determined relative to the midsternum in 111 patients irradiated during a 12-month period. In the second analysis, the difference between anticipated (pre-CT) and actual (CT-based) tangential field borders was assessed in 254 patients irradiated during a 2-year period.
RESULTS: In the first analysis, the depth of the IMVs varied from 1 to 6 cm (median 2.4 cm). The lateral distance from the midsternum also varied widely (range 1.7 to 3.7 cm, median 2.5 cm). Similar variability was found in the position of the GBT. In the second analysis, CT information led to changes of anticipated field borders in 65% of patients. The lateral border was shifted in 56% of patients (anteriorly 18%, posteriorly 38%). When the patients were segregated based on internal mammary node (IMN) treatment, the medial border was shifted in 49% of patients when the IMNs were treated in the tangential fields and in 24% when the GBT only was treated. The frequency of lateral field border shifts was similar in both groups.
CONCLUSIONS: The position of IMVs and GBT varies widely in breast cancer patients. Tangential field borders based on surface anatomy may not be ideal. Among 254 breast cancer patients, the field borders were shifted in 65% of patients when CT information was available. Thus, in most breast cancer patients, field borders are shifted when CT-based treatment planning is used.

Entities:  

Mesh:

Year:  1999        PMID: 10421534     DOI: 10.1016/s0360-3016(99)00123-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Different methods for target volume delineation of glandular breast tissue following breast-conserving surgery in breast cancer: A comparative study.

Authors:  Min Xu; Jianbin Li; Shanshan Liu; Suzhen Wang; Wei Wang; Fengxiang Li; Tonghai Liu; Jinming Yu
Journal:  Oncol Lett       Date:  2015-06-10       Impact factor: 2.967

2.  Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082.

Authors:  Lawrence B Marks; Constance Cirrincione; Thomas J Fitzgerald; Frances Laurie; Arvin S Glicksman; James Vredenburgh; Leonard R Prosnitz; Elizabeth J Shpall; Michael Crump; Paul G Richardson; Michael W Schuster; Jinli Ma; Bercedis L Peterson; Larry Norton; Steven Seagren; I Craig Henderson; David D Hurd; William P Peters
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-09       Impact factor: 7.038

3.  Does ultrasound provide any added value in breast contouring for radiotherapy after conserving surgery for cancer?

Authors:  Cynthia Aristei; Isabella Palumbo; Lorenzo Falcinelli; Rossana Crisci; Laura Cardinali; Barbara Palumbo; Valentina Lancellotta; Giampaolo Montesi; Gianni Gobbi; Claudio Zucchetti; Vittorio Bini
Journal:  Radiat Oncol       Date:  2015-08-22       Impact factor: 3.481

4.  Impact of clinical and pathological factors on local recurrence after breast-conserving treatment: CT-based localization for a tumor bed boost yielded better local control when compared with a surgical scar.

Authors:  Lize Wang; Jinfeng Li; Tianfeng Wang; Yuntao Xie; Zhaoqing Fan; Yingjian He; Tao Ouyang
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

5.  Dosimetric consequences of the shift towards computed tomography guided target definition and planning for breast conserving radiotherapy.

Authors:  Hans Paul van der Laan; Wil V Dolsma; John H Maduro; Erik W Korevaar; Johannes A Langendijk
Journal:  Radiat Oncol       Date:  2008-01-31       Impact factor: 3.481

6.  Initial Clinical Experience Treating Patients with Breast Cancer on a 6-MV Flattening-Filter-Free O-Ring Linear Accelerator.

Authors:  Andrew R Barsky; Fionnbarr O'Grady; Christopher Kennedy; Neil K Taunk; Lei Dong; James M Metz; Taoran Li; Gary M Freedman
Journal:  Adv Radiat Oncol       Date:  2019-06-08

7.  Breast clinical target volume: HU-based glandular CTVs and ESTRO CTVs in modern and historical radiotherapy treatment planning.

Authors:  Marciana Nona Duma; Theresa Kulms; Stefan Knippen; Tobias Teichmann; Andrea Wittig
Journal:  Strahlenther Onkol       Date:  2021-09-03       Impact factor: 3.621

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.